Back
Oncolytics Biotech, Inc. 10K Form
Sell
31
ONCY
Oncolytics Biotech, Inc.
Last Price:
$0.99
Seasonality Move:
-1.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ONCY News And Ratings
See the #1 stock for the next 7 days that we like better than ONCY
ONCY Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 1255.7 |
Profitability
| EPS (TTM): | -0.28110 |
|---|---|
| Net Income (TTM): | $-25.3M |
| Gross Margin: | $-309.5K |
| Return on Equity: | -635.07% |
| Return on Assets: | -177.83% |
Oncolytics Biotech, Inc. Earnings Forecast
Key Oncolytics Biotech, Inc. Financial Ratios
-
Per Share Earnings over the last 26 years have been positive in 15 years.
Oncolytics Biotech, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ONCY |
| CUSIP: | 682310 |
| Website: | oncolyticsbiotech.com |
Debt
| Debt-to-Equity Ratio: | 7.26 |
|---|---|
| Current Ratio: | 1.84 |
| Quick Ratio: | 1.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ONCY Technical Analysis vs Fundamental Analysis
Sell
31
Oncolytics Biotech, Inc. (ONCY)
is a Sell
Is Oncolytics Biotech, Inc. a Buy or a Sell?
-
Oncolytics Biotech, Inc. stock is rated a SellThe current Oncolytics Biotech, Inc. [ONCY] share price is $0.98. The Score for ONCY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.